[HTML][HTML] HPV vaccines–a review of the first decade
DM Harper, LR DeMars - Gynecologic oncology, 2017 - Elsevier
Abstract Pre-adolescent girls (9–15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …
vaccine series at either a six month or one year interval to provide protection from HPV 16 …
HPV vaccines-A review of the first decade
DM Harper, LR DeMars - Gynecologic oncology, 2017 - pubmed.ncbi.nlm.nih.gov
Pre-adolescent girls (9-15years) have the option of receiving a two dose HPV vaccine series
at either a six month or one year interval to provide protection from HPV 16, the most …
at either a six month or one year interval to provide protection from HPV 16, the most …
HPV vaccines-a review of the first decade.
DM Harper, LR DeMars - 2017 - cabidigitallibrary.org
Abstract Pre-adolescent girls (9-15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …
vaccine series at either a six month or one year interval to provide protection from HPV 16 …
HPV vaccines–A review of the first decade
DM Harper, LR DeMars - Gynecologic Oncology, 2017 - gynecologiconcology-online.net
Abstract Pre-adolescent girls (9–15years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …
vaccine series at either a six month or one year interval to provide protection from HPV 16 …
[引用][C] HPV vaccines–A review of the first decade
DM Harper, LR DeMars - Gynecologic Oncology, 2017 - cir.nii.ac.jp
HPV vaccines – A review of the first decade | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
HPV vaccines-A review of the first decade.
DM Harper, LR DeMars - Gynecologic Oncology, 2017 - europepmc.org
HPV vaccines - A review of the first decade. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …
[PDF][PDF] HPV vaccines–A review of the first decade
DM Harper, LR DeMars - Gynecologic Oncology, 2017 - researchgate.net
• Do not use Gardasil9 as a booster vaccine for those already vaccinated.• Gardasil9 and
Cervarix are equivalent in efficacy against CIN 2+ regardless of HPV type.• Only two doses …
Cervarix are equivalent in efficacy against CIN 2+ regardless of HPV type.• Only two doses …
[PDF][PDF] HPV vaccines–A review of the first decade
DM Harper, LR DeMars - Gynecologic Oncology, 2017 - wisnerbaum.com
• Do not use Gardasil9 as a booster vaccine for those already vaccinated.• Gardasil9 and
Cervarix are equivalent in efficacy against CIN 2+ regardless of HPV type.• Only two doses …
Cervarix are equivalent in efficacy against CIN 2+ regardless of HPV type.• Only two doses …
[PDF][PDF] HPV vaccines–A review of the first decade
DM Harper, LR DeMars - Gynecologic Oncology, 2017 - researchgate.net
• Do not use Gardasil9 as a booster vaccine for those already vaccinated.• Gardasil9 and
Cervarix are equivalent in efficacy against CIN 2+ regardless of HPV type.• Only two doses …
Cervarix are equivalent in efficacy against CIN 2+ regardless of HPV type.• Only two doses …
Corrigendum to" HPV vaccines-A review of the first decade"[Gynecol. Oncol. 146 (2017) 196-204]
DM Harper, LR DeMars - Gynecologic oncology, 2017 - pubmed.ncbi.nlm.nih.gov
Corrigendum to "HPV vaccines-A review of the first decade" [Gynecol. Oncol. 146 (2017)
196-204] Corrigendum to "HPV vaccines-A review of the first decade" [Gynecol. Oncol. 146 (2017) …
196-204] Corrigendum to "HPV vaccines-A review of the first decade" [Gynecol. Oncol. 146 (2017) …